Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
New India programme supports tribal families hosting tourists - 2African Forests Have Become a Source of Carbon Emissions
- 3In a scientific first, biologists recorded a wild wolf potentially using tools
- 4AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- 5The most effective method to Comprehend the Variables Affecting Medical attendant Pay rates
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- Medtronic has 'significant firepower' for multiple acquisitions, executives say
- Horses really can smell our fear, new study finds
- Instructions to Decide whether a Fender bender Legal counselor is Required for Your Particular Case
- I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
- New materials, old physics – the science behind how your winter jacket keeps you warm
- Top notch Remote Earphones for Audiophiles
- Your big brain makes you human – count your neurons when you count your blessings
- Limited Rain Chances in Brazil Boost Coffee Prices
